At a glance
- Originator Bristol-Myers Squibb
- Class Anti-infectives; Cycloparaffins; Cytostatic antibiotics; Enediynes; Naphthalenes
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer